# A Study in Evaluating Bioequivalence Between Test and Reference Formulations of Vadadustat Tablets in Healthy Adults

> **NCT03639155** · PHASE1 · COMPLETED · sponsor: **Akebia Therapeutics** · enrollment: 50 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** vadadustat reference tablets
- **DRUG:** vadadustat test tablets

## Key facts

- **NCT ID:** NCT03639155
- **Lead sponsor:** Akebia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-12
- **Primary completion:** 2018-05-23
- **Final completion:** 2018-05-23
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03639155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03639155, "A Study in Evaluating Bioequivalence Between Test and Reference Formulations of Vadadustat Tablets in Healthy Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03639155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*